O TYM ODCINKU
June 27th 2024 – Join us this week as we speak with Kevin Neil and Jean-François Millau from Tatum Bioscience in Sherbrooke, Quebec. Kevin and Jean-François are a part of a team that are ‘programming’ bacteria to turn them into cancer-fighting drugs and the work they are doing is cutting edge.
TATUM Bioscience: tatumbio.com
Get Your Tickets to The NGBI Summit: nextgreatbigideas.com
Lab Occupier: laboccupier.com
Język angielski
Stany Zjednoczone
TRANSKRYPCJA 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
WYSZUKAJ MINIONE ODCINKI
Wyszukaj minione odcinki NGBiLab.
INNE ODCINKI W TYM PODCASCIE
In this episode, we delve into the groundbreaking work of Dr. Jeffrey Coull and his team at Grey Matter Neurosciences. Discover how their pioneering ultrasound technology aims to enhance cognitive function in patients with Alzheimer's and other cognitive impairments. Join us as we explore the poten…
Join host Jim Wilson as he sits down with Nabanita Nawar, co-founder of HDAX Therapeutics, to explore the groundbreaking work in targeting disease driver proteins for novel medicine development. Discover the journey from academic research to entrepreneurial success, and learn about the innovative t…
Zastrzeżenie: Podcast i grafika osadzone na tej stronie pochodzą z Jim Wilson, który jest własnością jego właściciela i nie jest powiązany ani wspierany przez Listen Notes, Inc.
EDYTUJ
Dziękujemy za pomoc w aktualizowaniu podcastowej bazy danych.
